Once you and your doctor agree it is time to look beyond another antidepressant, a new problem appears: which provider? In St. Peters, you may find several options within a reasonable drive, and each one looks good on its website. This guide gives you a way to compare them that reflects what people in this region actually care about.
It is organized around one question from our summer poll, which had 443 adults in ten Midwest states pick the two traits they would weigh most in a ketamine or esketamine provider. Their final, validated answers make a ready scorecard.
The scorecard, in the order people ranked it
- Accepts my insurance: 85 percent
- A reasonable drive: 43 percent
- The FDA signed off: 27 percent
- Relief comes quickly: 24 percent
- Discreet visits: 11 percent
- Experienced with veterans or first responders: 10 percent
Your own priorities may differ. But if you are unsure where to start, this order is a practical one.
Factor one: does the provider take your coverage?
Nearly everyone in the survey put this near the top, and for good reason. It usually decides whether the rest of the list matters.
Questions to ask the provider's office:
- "Do you accept my plan, [plan name], for esketamine treatment?"
- "Are you in network for both the medication and the visit?"
- "Who handles prior authorization, you or my doctor?"
- "What will I likely owe per session?"
Then confirm with your plan. A provider's office may say yes in good faith and still be out of network for your specific product. If you are on MO HealthNet, name your managed care plan, not just Medicaid.
Factor two: how close is it, really?
St. Peters sits along I-70 in the middle of St. Charles County, which puts providers in O'Fallon, St. Charles, and west St. Louis County within reach on a good day. But for esketamine, "within reach" needs a closer look.
Here is why. The approved product, Spravato, is esketamine in spray form for adults whose depression outlasted other treatment, and only certified sites give it. You stay a couple of hours under observation after each dose and do not drive until tomorrow. Early in treatment, visits come often.
So for each provider, ask yourself:
- How long is the drive at the time of day my appointments would be?
- Who will drive me, and what does it cost them in time off work?
- Is there a closer covered option I have not found yet?
If transportation is a real barrier, find out whether your plan will pay for a ride to each session. The Brain Recovery Centers overview of esketamine costs and coverage covers what plans commonly require.
Factor three: what do they say about results?
About a quarter of respondents valued fast results. It is natural to want relief quickly. But be careful with any provider that promises it. No one can promise how a particular person will respond to any depression treatment.
Better questions:
- "How do you measure whether treatment is working?"
- "What happens if I do not respond?"
- "Will you coordinate with my regular doctor?"
A provider who answers with a tracking plan rather than a promise is showing you how they think.
Factor four: is the treatment FDA-approved?
Approval ran only slightly ahead of speed in the two-pick ranking, but it matters more than that suggests. Scored on its own, FDA approval mattered a great deal, or decided things, for 59 percent of respondents.
The key question to ask: "Are you offering esketamine, the FDA-approved nasal spray, or ketamine by infusion or at home?" IV and home-use ketamine are off-label for depression, sit outside that approval, are frequently cash-pay, and home programs are more lightly supervised. None of that makes them wrong for everyone, but you deserve to know which you are choosing.
Factor five: how private is it?
Eleven percent of respondents ranked privacy in their top two. If it matters to you, ask:
- "Where do patients wait during the monitoring period?"
- "Is the treatment room private?"
- "How do you handle communication with my employer or family, if at all?"
Factor six: do they have experience with people like me?
A veteran or first responder specialty made the two-item list for 10 percent. If you are one, or you are choosing for someone who is, ask about the staff's experience with trauma, shift work, and the particular pressures of those jobs. You might also ask whether they accept TRICARE.
A worksheet you can use
For each provider you are considering, jot down:
- Covered? Yes, no, or pending authorization.
- Drive time for my driver, round trip.
- How they track progress.
- Esketamine or off-label ketamine.
- Privacy arrangements.
- Relevant experience.
Side by side, the choice is often obvious. When two are close, pick the one your plan covers with fewer unknowns and your driver can reach on a weekday.
Bring it to your doctor
Most respondents would start with a doctor: 56 percent named primary care first, and a physician's recommendation would move 74 percent. Bring your worksheet. Your doctor decides whether esketamine suits you at all, and may know which of the local options have worked well for other patients.
This guide is no substitute for medical advice. The esketamine approval covers one condition, fit varies, and no treatment's outcome is certain.
If you are in crisis, set the worksheet aside. Dial or text 988, a free and confidential Suicide and Crisis Lifeline that stays awake in St. Peters at every hour.
Methodology
St. Peters readers can trace our numbers to study 395586438, which Pollfish ran with panel members and shut on June 23, 2026. It holds 443 completes; the respondents, 18 through 64, live in Oklahoma, Iowa, Kansas, Missouri, Wisconsin, Ohio, Indiana, Nebraska, Illinois and Minnesota. Each chose two provider factors. The figures are whole-sample shares, and validation is complete. The publisher commissioned the poll and paid for all of it.